Pharmaceutical Pricing and Reimbursement Information (PPRI) is a networking and information-sharing initiative on burning issues of pharmaceutical policies from a public health perspective. It involves a network of around 60 institutions (mainly relevant authorities and third party payers) from all 27 European Union Member States plus more than ten further, mainly European, countries.
This on-going networking exercise results from the PPRI research project, co-funded by the European Commission, Directorate-General Public Health and Consumers, which was carried out from 2005 to 2007. In the course of the project the PPRI network was established, and a set of pharmaceutical indicators, filled with real data from 27 PPRI countries, as well as more than 20 country reports and brief overviews on the pharmaceutical systems (country information) were produced. For further information see the PPRI website: http://ppri.goeg.at
The PPRI project was selected by the Executive Agency for Health and Consumers, in collaboration with the Health Programme’s National Focal Points (NFP) and the Directorate General for Health and Consumers (DG SANCO) as a good practice example of a EU Public Health projects with an important impact for EU Member States (see brochure)
In the on-going PPRI initiative, the networking of the competent authorities continues, via regular networking meetings and continuous sharing of relevant information for decision-making, including an up-date of country-specific information.
The PPRI secretariat is hosted at the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies. The website of the Centre is designed to serve as an information platform about pharmaceutical policies. We have therefore included all relevant PPRI information in this website. Please note that this WHO CC website is the future key resource centre, while the PPRI website (running from 2005 till September 2011) will no longer be updated.